Home
Storia in 1 fonti
Why Iovance Biotherapeutics Stock Hit 52-Week High - Iovance Biotherapeutics (NASDAQ:IOVA)
Iovance Biotherapeutics stock hits a 52-week high as investors weigh Moderna-Merck cancer data, Amtagvi sales and analyst price target hikes.
Raccontata da
benzinga.com
Timeline cronologica
- ·
Why Iovance Biotherapeutics Stock Hit 52-Week High - Iovance Biotherapeutics (NASDAQ:IOVA)
Iovance Biotherapeutics stock hits a 52-week high as investors weigh Moderna-Merck cancer data, Amtagvi sales and analyst price target hikes.
- ·
Iovance Biotherapeutics Stock Is Trending Friday: What's Going On? - Iovance Biotherapeutics (NASDAQ:IOVA
Shares of Iovance Biotherapeutics are trending Friday morning after a momentum surge pushed the biotech stock to a new 52-week high.